Csenge Advisory Group Has $1.52 Million Position in Aflac Incorporated (NYSE:AFL)

Csenge Advisory Group reduced its position in shares of Aflac Incorporated (NYSE:AFLFree Report) by 3.8% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 14,656 shares of the financial services provider’s stock after selling 573 shares during the period. Csenge Advisory Group’s holdings in Aflac were worth $1,516,000 at the end of the most recent quarter.

Other institutional investors and hedge funds also recently modified their holdings of the company. Spinnaker Trust raised its holdings in Aflac by 2.7% during the third quarter. Spinnaker Trust now owns 3,620 shares of the financial services provider’s stock worth $405,000 after acquiring an additional 95 shares in the last quarter. Phillips Wealth Planners LLC raised its holdings in Aflac by 1.5% during the fourth quarter. Phillips Wealth Planners LLC now owns 6,553 shares of the financial services provider’s stock worth $662,000 after acquiring an additional 100 shares in the last quarter. Raleigh Capital Management Inc. raised its holdings in Aflac by 23.2% during the fourth quarter. Raleigh Capital Management Inc. now owns 531 shares of the financial services provider’s stock worth $55,000 after acquiring an additional 100 shares in the last quarter. New Century Financial Group LLC raised its holdings in Aflac by 2.5% during the third quarter. New Century Financial Group LLC now owns 4,198 shares of the financial services provider’s stock worth $469,000 after acquiring an additional 101 shares in the last quarter. Finally, Covestor Ltd raised its holdings in Aflac by 41.8% during the third quarter. Covestor Ltd now owns 363 shares of the financial services provider’s stock worth $41,000 after acquiring an additional 107 shares in the last quarter. 67.44% of the stock is owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

Several research firms recently issued reports on AFL. BMO Capital Markets began coverage on Aflac in a report on Thursday, January 23rd. They set a “market perform” rating and a $111.00 target price on the stock. Evercore ISI dropped their target price on Aflac from $104.00 to $102.00 and set an “underperform” rating on the stock in a report on Wednesday, December 4th. StockNews.com upgraded Aflac from a “sell” rating to a “hold” rating in a research note on Friday. JPMorgan Chase & Co. upped their price objective on Aflac from $90.00 to $94.00 and gave the company a “neutral” rating in a research note on Tuesday, January 7th. Finally, Truist Financial upped their price objective on Aflac from $100.00 to $105.00 and gave the company a “hold” rating in a research note on Friday, November 1st. Two research analysts have rated the stock with a sell rating, eleven have assigned a hold rating and two have assigned a buy rating to the company’s stock. Based on data from MarketBeat, the company presently has an average rating of “Hold” and a consensus target price of $103.00.

Check Out Our Latest Analysis on AFL

Insider Buying and Selling

In related news, EVP Audrey B. Tillman sold 24,744 shares of the stock in a transaction that occurred on Friday, December 27th. The stock was sold at an average price of $103.40, for a total transaction of $2,558,529.60. Following the sale, the executive vice president now owns 222,618 shares of the company’s stock, valued at $23,018,701.20. This represents a 10.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through the SEC website. 0.90% of the stock is currently owned by company insiders.

Aflac Price Performance

Shares of NYSE AFL opened at $103.46 on Monday. The firm has a market cap of $57.48 billion, a P/E ratio of 10.78, a price-to-earnings-growth ratio of 2.10 and a beta of 0.99. The company has a current ratio of 0.10, a quick ratio of 0.08 and a debt-to-equity ratio of 0.29. Aflac Incorporated has a 1-year low of $78.38 and a 1-year high of $115.50. The business’s 50 day moving average is $104.18 and its 200-day moving average is $107.17.

Aflac (NYSE:AFLGet Free Report) last announced its earnings results on Wednesday, February 5th. The financial services provider reported $1.56 earnings per share for the quarter, missing analysts’ consensus estimates of $1.63 by ($0.07). Aflac had a return on equity of 16.20% and a net margin of 28.76%. Equities research analysts predict that Aflac Incorporated will post 6.95 earnings per share for the current year.

Aflac Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Monday, March 3rd. Investors of record on Wednesday, February 19th will be given a dividend of $0.58 per share. The ex-dividend date of this dividend is Wednesday, February 19th. This represents a $2.32 dividend on an annualized basis and a yield of 2.24%. This is an increase from Aflac’s previous quarterly dividend of $0.50. Aflac’s dividend payout ratio is currently 20.83%.

About Aflac

(Free Report)

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.

Featured Articles

Institutional Ownership by Quarter for Aflac (NYSE:AFL)

Receive News & Ratings for Aflac Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aflac and related companies with MarketBeat.com's FREE daily email newsletter.